Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 69,141 | 94,770 | 85,297 | 153,282 | 108,887 |
| Cost of Goods | 3,126 | 3,334 | 3,594 | 46,930 | 34,581 |
| Gross Profit | 66,015 | 91,436 | 81,703 | 106,352 | 74,306 |
| Operating Expenses | 330,668 | 239,728 | 197,398 | 144,725 | 126,528 |
| Operating Income | -264,527 | -147,958 | -115,101 | -37,443 | -51,641 |
| Interest Expense | 17,298 | 17,684 | 19,318 | 11,653 | 1,704 |
| Other Income | 15,412 | 28,684 | 54,190 | 17,517 | 12,191 |
| Pre-tax Income | -266,413 | -136,958 | -80,229 | -31,579 | -41,154 |
| Net Income Continuous | -266,413 | -136,958 | -80,229 | -31,579 | -41,154 |
| Net Income Discontinuous | 69,646 | 28,337 | 22,148 | N/A | N/A |
| Net Income | $-196,767 | $-108,621 | $-66,233 | $-34,740 | $-41,154 |
| EPS Basic Total Ops | -2.56 | -1.43 | -0.89 | -0.51 | -0.66 |
| EPS Basic Continuous Ops | -3.46 | -1.81 | -1.08 | -0.47 | -0.66 |
| EPS Basic Discontinuous Ops | 0.90 | 0.38 | 0.30 | N/A | N/A |
| EPS Diluted Total Ops | -2.56 | -1.43 | -0.89 | -0.51 | -0.66 |
| EPS Diluted Continuous Ops | -3.46 | -1.81 | -1.08 | -0.47 | -0.66 |
| EPS Diluted Discontinuous Ops | 0.90 | 0.38 | 0.30 | N/A | N/A |
| EBITDA(a) | $-241,089 | $-123,053 | $-97,299 | $-24,651 | $-41,970 |